
Join to View Full Profile
101 Page St"# Southcoa"New Bedford, MA 02740
Phone+1 508-961-5919
Fax+1 508-961-5916
Are you Dr. Sica?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Roberto Sica, MD is an oncologist in New Bedford, Massachusetts. He is currently licensed to practice medicine in Massachusetts, New York, and California.
Education & Training
- Steward Carney HospitalResidency, Internal Medicine, 2007 - 2010
- University of Buenos AiresClass of 1998
Certifications & Licensure
- CA State Medical License 2016 - 2026
- CA State Medical License 2016 - 2026
- IL State Medical License 2014 - 2026
- MA State Medical License 2010 - 2026
- NY State Medical License 2018 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies.Dennis L Cooper, Jhannine Alyssa Verceles, Taba Kheradmand, Monika Paroder, Amanda Lombardo
British Journal of Haematology. 2025-03-01 - 5 citationsOutcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, Riya Patel, Rama Al Hamed
Clinical Hematology International. 2023-06-01 - 3 citationsLenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B Donnellan, Jesus Berdeja
Clinical Cancer Research. 2023-01-04
Press Mentions
- Should Therapy for Hematologic Malignancies Be Modified to Mitigate Poor COVID-19 Outcomes?February 25th, 2021